# 116-hr-8190: Biosimilar Insulin Access Act of 2020

116-hr-8190, Biosimilar Insulin Access Act of 2020, is a 116th Congress bill sponsored by Rep. Grothman, Glenn [R-WI-6] (R-WI); status Sponsor introductory remarks on measure. (CR H4487) (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/116-hr-8190
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 116-hr-8190
- Congress: 116
- Title: Biosimilar Insulin Access Act of 2020
- Status: Sponsor introductory remarks on measure. (CR H4487)
- Introduced: 2020-09-08
- Sponsor: Rep. Grothman, Glenn [R-WI-6] (R-WI)
- Cosponsors: 1
- Policy area: Health
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

Biosimilar Insulin Access Act of 2020 This bill establishes that, if the Food and Drug Administration (FDA) finds that an insulin is biosimilar to a reference product, the insulin shall be deemed interchangeable with the reference product. (A biological product is biosimilar to a reference product if the two products are highly similar and have no clinically meaningful differences; the reference product generally receives FDA approval first, but the biosimilar product is typically less expensive.) Under current law, a biological product that is biosimilar to a reference product may be deemed interchangeable with the reference product only if it meets additional requirements. Current law provides that interchangeable products may be substituted for each other without the prescriber's involvement.

## Cosponsors (1)

- Del. San Nicolas, Michael F. Q. [D-GU-At Large] (D-GU), 2020-11-17T00:00:00.000Z

## Related bills

- 116-hr-7873: Epi for Dilly Act of 2020
- 116-hr-6556: Gabriella Miller Kids First Research Act 2.0
- 116-hr-6082: Forgotten Vietnam Veterans Act
- 116-hr-5957: K2 Veterans Toxic Exposure Accountability Act of 2020
- 116-hr-4634: Terrorism Risk Insurance Program Reauthorization Act of 2019
- 116-hr-1865: Further Consolidated Appropriations Act, 2020

## Sources
- [116-hr-8190 on Congress.gov](https://www.congress.gov/bill/116th-congress/house-bill/8190)

## Related
- [116-hr-7873: Epi for Dilly Act of 2020](https://policyrisk.com/legislation/116-hr-7873)
- [116-hr-6556: Gabriella Miller Kids First Research Act 2.0](https://policyrisk.com/legislation/116-hr-6556)
- [116-hr-6082: Forgotten Vietnam Veterans Act](https://policyrisk.com/legislation/116-hr-6082)
- [116-hr-5957: K2 Veterans Toxic Exposure Accountability Act of 2020](https://policyrisk.com/legislation/116-hr-5957)
- [116-hr-4634: Terrorism Risk Insurance Program Reauthorization Act of 2019](https://policyrisk.com/legislation/116-hr-4634)
- [116-hr-1865: Further Consolidated Appropriations Act, 2020](https://policyrisk.com/legislation/116-hr-1865)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/116-hr-8190 (as of 2025-11-18).